{"url_path":"/sec/cgtx/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1455365/0001104659-26-057545-index.html","accession_number":"0001104659-26-057545","cik":"0001455365","ticker":"CGTX","issuer_name":"COGNITION THERAPEUTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1455365/0001104659-26-057545-index.html","primary_entity_key":"0001455365","primary_entity_name":"COGNITION THERAPEUTICS INC"},"word_count":41,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds\n\n**Recent Sales of Unregistered Securities**\n\nThere were no unregistered sales of our equity securities during the fiscal quarter ended March 31, 2026.\n\n**Repurchase of Shares of Company Equity Securities**\n\nNone."}